A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel
- 22 April 2015
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 98 (3), 568-573
- https://doi.org/10.1016/j.yexmp.2015.04.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- COSMIC: exploring the world's knowledge of somatic mutations in human cancerNucleic Acids Research, 2014
- Copy number variants in clinical next-generation sequencing data can define the relationship between simultaneous tumors in an individual patientExperimental and Molecular Pathology, 2014
- EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus SequencingCancer Discovery, 2014
- Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing dataExperimental and Molecular Pathology, 2014
- Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted TherapiesPLoS Currents, 2014
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices PipelineCurrent Protocols in Bioinformatics, 2013
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of GlioblastomaCancer Cell, 2012
- PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomasGenes & Development, 2010
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008